Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
Single centre, randomised, open-label, two-way crossover study to investigate whether
multiple-dose administration of eslicarbazepine acetate (ESL, BIA 2-093) affects the
pharmacokinetics of gliclazide.